Principia Biopharma is Biotechnology in United States that focus on Tailored Covalency platform enables business. Founded in 2008. They cover business area such as novel therapy, immunology, oncology, its proprietary Tailored Covalency platform enable, potency, selectivity, BTK franchise.
2008
( 16 years old in 2024 )
Tailored Covalency Platform Enables
-
220 East Grand Avenue
Suite 302
San Francisco, CA 94080
United States
Private
novel therapyimmunologyoncologyits proprietary Tailored Covalency platform enablepotencyselectivityBTK franchise
* We use standard office opening hours in near Principia Biopharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Principia Biopharma is Biotechnology business from United States that founded in 2008 (16 years old in 2024), Principia Biopharma business is focusing on Tailored Covalency Platform Enables.
Principia Biopharma headquarter office and corporate office address is located in 220 East Grand Avenue Suite 302 San Francisco, CA 94080 United States.
Principia Biopharma was founded in United States.
In 2024, Principia Biopharma is currently focus on Tailored Covalency platform enables sector.
Above is snippet of Google Trends for "Tailored Covalency platform enables" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Principia Biopharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
